thumbnail_Pan-Biome-logo.png
Pan-Biome Pharmaceuticals, Inc. provides update on its longevity research program: its compounds modulate inflammation, the gut microbiome, and increase lifespan of C. elegans by 30%
02 déc. 2021 10h00 HE | Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc., a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals, Inc. adds skin disease and microbiome specialists Drs. Youwen Zhou and Andy Sham to Its Newly Created Scientific Advisory Board
02 juin 2021 08h00 HE | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin health and healthy ageing,...
Blue California Opens New Possibilities in Functional Food and Beverages Following Dihydroquercetin (DHQ) GRAS Status
25 mai 2021 05h39 HE | Blue California Ingredients
Rancho Santa Margarita, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Blue California’s Taxifolin BC-DHQ® with super antioxidant and anti-inflammatory properties is now Generally Recognized As Safe...
thumbnail_Pan-Biome-logo.png
Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome
24 févr. 2021 10h00 HE | Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...
Blue California Files Patent on the Use of Ergothioneine as a Support for Oxidative Stress Related Health Conditions, including COVID-19
14 juil. 2020 17h37 HE | Blue California Ingredients
Rancho Santa Margarita, Calif and Bedford, Mass., July 14, 2020 (GLOBE NEWSWIRE) -- Blue California, a science-based, innovative ingredient solution provider, has just filed for a patent on...
Reports and Data.jpeg-01
Lactoferrin Market To Reach USD 329.7 Million By 2026 | Reports And Data
28 janv. 2020 14h00 HE | Reports and Data
New York, Jan. 28, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global Lactoferrin market was valued at USD 189.6 million in 2018 and is expected to reach USD...
wedderspoon products
Business Capital Delivers $5.5 Million Financing for Wedderspoon
14 janv. 2020 07h00 HE | Business Capital
SAN FRANCISCO, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Business Capital structured and delivered a $5.5MM  working capital facility for Wedderspoon, the largest seller of Manuka honey and its portfolio of...
Therapeutics Solutions International, Inc LOGO.png
Therapeutic Solutions International Develops Glucoraphanin + NanoStilbene Encapsulated product for reduction of Prostate Specific Antigen (PSA)
08 juil. 2019 09h00 HE | Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutic Solutions International, Inc., (OTC Markets: TSOI) announced today the development of a broccoli sprout extract...
Addivant™ Receives F
Addivant™ Receives Formal Food-Contact Approval From MERCOSUR Region For WESTON® 705 Nonylphenol-Free Antioxidant
28 août 2018 10h13 HE | Addivant
DANBURY, Conn., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Addivant™, the world leading supplier of liquid phosphite antioxidants for plastics, announced today that its nonylphenol-free stabilizer, WESTON®...
Nutrex Hawaii Earns
Nutrex Hawaii Earns IGEN™ Verification for its BioAstin® Hawaiian Astaxanthin® Natural Microalgae Products
06 mars 2018 06h00 HE | Nutrex Hawaii
KAILUA-KONA, Hawaii, March 06, 2018 (GLOBE NEWSWIRE) -- Nutrex Hawaii, Inc. is pleased to announce that its BioAstin® Hawaiian Astaxanthin® and MD Formulas™ have received The International GMO...